Correction to "Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension"

DOI: https://doi.org/10.1002/pul2.12417

2024-07-17

Abstract:[This corrects the article DOI: 10.1002/pul2.12398.].

What problem does this paper attempt to address?

Erratum: Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

Min Wang,Qingbo Lv,Liding Zhao,Yao Wang,Yi Luan,Zhengwei Li,Guosheng Fu,Wenbin Zhang

DOI: https://doi.org/10.3892/etm.2022.11134

IF: 2.7

2022-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2019.8312.].
Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Shufang Fu,Xin Wen,Fei Han,Longwei Yin,Gaosi Xu

DOI: https://doi.org/10.18632/oncotarget.24255

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.19382.].
Erratum: "Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges". Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour. ERJ Open Res 2022; 8: 00115-2022

DOI: https://doi.org/10.1183/23120541.50115-2022

2022-10-03

Abstract:[This corrects the article DOI: 10.1183/23120541.00115-2022.].
Correction to: Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy

DOI: https://doi.org/10.1093/eurheartjsupp/suae071

2023-04-26

Abstract:[This corrects the article DOI: 10.1093/eurheartjsupp/suad074.].
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Yusi Chen,Jun Luo,Jingyuan Chen,Eugene Kotlyar,Zilu Li,Wenjie Chen,Jiang Li

DOI: https://doi.org/10.3389/fphar.2022.891907

IF: 5.6

2022-04-11

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.811700.].

pharmacology & pharmacy
Correction to: Cardiogenic shock without hypotension in acute severe primary mitral regurgitation: a case report

DOI: https://doi.org/10.1093/omcr/omae136

2024-09-12

Abstract:[This corrects the article DOI: 10.1093/omcr/omae018.].
Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

Yang-Yang He,Xin-Mei Xie,Hong-Da Zhang,Jue Ye,Selin Gencer,Emiel P. C. van der Vorst,Yvonne Döring,Christian Weber,Xiao-Bin Pang,Zhi-Cheng Jing,Yi Yan,Zhi-Yan Han

DOI: https://doi.org/10.3389/fphar.2021.810178

IF: 5.6

2021-12-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.753727.].

pharmacology & pharmacy
Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Yu-Yang Liu,Yi-Yang Qu,Shang Wang,Ci-Jun Luo,Hong-Ling Qiu,Hui-Ting Li,Ping Yuan,Lan Wang,Jin-Ling Li,Rong Jiang,Rui Zhang

DOI: https://doi.org/10.3389/fphar.2023.1155631

IF: 5.6

2023-02-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1052546.].

pharmacology & pharmacy
Erratum: "A pulmonary rehabilitation shared decision-making intervention for patients living with COPD: PReSent: protocol for a feasibility study". Amy C. Barradell, Linzy Houchen-Wolloff, Noelle Robertson, Hilary L. Bekker and Sally J. Singh. ERJ Open Res 2022; 8: 00645-2021

DOI: https://doi.org/10.1183/23120541.50645-2021

2022-07-04

Abstract:[This corrects the article DOI: 10.1183/23120541.00645-2021.].
Erratum: "Lung diffusing capacity for nitric oxide measured by two commercial devices: a randomised crossover comparison in healthy adults". Thomas Radtke, Quintin de Groot, Sarah R. Haile, Marion Maggi, Connie C.W. Hsia and Holger Dressel. ERJ Open Res 2021; 7: 00193-2021

DOI: https://doi.org/10.1183/23120541.50193-2021

2021-09-13

Abstract:[This corrects the article DOI: 10.1183/23120541.00193-2021.].
Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]

Jing Zhu,Xian-he Lin

DOI: https://doi.org/10.1016/j.heliyon.2023.e17578

IF: 3.776

2023-06-01

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2023.e15311.].
Correction to Lancet Rheumatol 2020; 2: e557-64

DOI: https://doi.org/10.1016/S2665-9913(21)00137-5

Abstract:[This corrects the article DOI: 10.1016/S2665-9913(20)30227-7.].
Correction to: Double-territory STEMI with cardiogenic shock in immune thrombocytopenic purpura with severe thrombocytopenia-a case report

DOI: https://doi.org/10.1093/ehjcr/ytae519

2024-09-24

Abstract:[This corrects the article DOI: 10.1093/ehjcr/ytae345.].
Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension

Dirk Habedank,Till Ittermann,Sabine Kaczmarek,Beate Stubbe,Alexander Heine,Anne Obst,Ralf Ewert

DOI: https://doi.org/10.1002/pul2.12398

2024-06-19

Pulmonary Circulation

Abstract:Parameters of cardiopulmonary exercise testing significantly discriminate between healthy subjects and patients with pulmonary hypertension (PH), also according to the new 2022 definition of pulmonary hypertension (mean pulmonary arterial pressure mPAP > 20 mmHg). The cut‐offs indicating on PH were peakVO2 ≤ 16.7 mL/min/kg (Youden‐Index YI = 0.79), petCO2@AT ≤ 34 mmHg (YI = 0.67), and VE/VCO2@AT ≤ 30 (YI = 0.76).

cardiac & cardiovascular systems,respiratory system
Erratum: The Neutrophil/Lymphocyte Ratio Could Predict Noninvasive Mechanical Ventilation Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study [Corrigendum]

DOI: https://doi.org/10.2147/COPD.S452161

2023-12-22

Abstract:[This corrects the article DOI: 10.2147/COPD.S320529.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Yan-Mei Wang,Shou-Ling Mi,Hong Jin,Qi-Lin Guo,Zhong-Yu Yu,Jian-Tao Wang,Xiao-Ming Zhang,Qian Zhang,Na-Na Wang,Yan-Yan Huang,Hou-Guang Zhou,Jing-Chun Guo

DOI: https://doi.org/10.3389/fphar.2021.827490

IF: 5.6

2022-01-03

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.754387.].

pharmacology & pharmacy
Correction to: Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach

DOI: https://doi.org/10.1093/ofid/ofae509

2024-09-05

Abstract:[This corrects the article DOI: 10.1093/ofid/ofae462.].
Correction to: Tackling cardiovascular healthcare disparities for the LGBTQIA+ population: a call to action

DOI: https://doi.org/10.1093/eurheartj/ehae269

IF: 39.3

2024-05-11

European Heart Journal

Abstract:This is a correction to: Alexander Kharlamov, Nigel Sherriff, Christian Delles, Pim van der Harst, Tackling cardiovascular healthcare disparities for the LGBTQIA+ population: a call to action, European Heart Journal , 2024, ehad882, https://doi.org/10.1093/eurheartj/ehad882.

cardiac & cardiovascular systems

Correction to "Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension"

Erratum: Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Erratum: "Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges". Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour. ERJ Open Res 2022; 8: 00115-2022

Correction to: Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Correction to: Cardiogenic shock without hypotension in acute severe primary mitral regurgitation: a case report

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Erratum: "A pulmonary rehabilitation shared decision-making intervention for patients living with COPD: PReSent: protocol for a feasibility study". Amy C. Barradell, Linzy Houchen-Wolloff, Noelle Robertson, Hilary L. Bekker and Sally J. Singh. ERJ Open Res 2022; 8: 00645-2021

Erratum: "Lung diffusing capacity for nitric oxide measured by two commercial devices: a randomised crossover comparison in healthy adults". Thomas Radtke, Quintin de Groot, Sarah R. Haile, Marion Maggi, Connie C.W. Hsia and Holger Dressel. ERJ Open Res 2021; 7: 00193-2021

Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]

Correction to Lancet Rheumatol 2020; 2: e557-64

Correction to: Double-territory STEMI with cardiogenic shock in immune thrombocytopenic purpura with severe thrombocytopenia-a case report

Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension

Erratum: The Neutrophil/Lymphocyte Ratio Could Predict Noninvasive Mechanical Ventilation Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study [Corrigendum]

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Correction to: Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach

Correction to: Tackling cardiovascular healthcare disparities for the LGBTQIA+ population: a call to action